CNBX Pharmaceuticals Inc. - CNBX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | 3i, LP | 9.9% | 169,341,400 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 169,341,400 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 169,341,400 | View |
| May 08, 2026 | SCHEDULE 13G/A | 3i, LP | 9.9% | 124,946,375 | View |
| May 08, 2026 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 124,946,375 | View |
| May 08, 2026 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 124,946,375 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | 3i, LP | 9.9% | 83,595,541 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 83,595,541 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 83,595,541 | View |
| Nov 10, 2025 | SCHEDULE 13G/A | 3i, LP | 9.9% | 80,865,244 | View |
| Nov 10, 2025 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 80,865,244 | View |
| Nov 10, 2025 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 80,865,244 | View |
| Aug 13, 2025 | SCHEDULE 13G/A | 3i, LP | 9.9% | 13,573,116 | View |
| Aug 13, 2025 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 13,573,116 | View |
| Aug 13, 2025 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 13,573,116 | View |
| May 13, 2025 | SCHEDULE 13G/A | 3i, LP | 9.9% | 3,420,088 | View |
| May 13, 2025 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 3,420,088 | View |
| May 13, 2025 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 3,420,088 | View |
| Feb 13, 2025 | SCHEDULE 13G/A | 3i, LP | 9.9% | 3,412,557 | View |
| Feb 13, 2025 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 3,412,557 | View |
| Feb 13, 2025 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 3,412,557 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.